FDA Approves Praluent (alirocumab) to Prevent Heart Attack, Stroke and Unstable Angina Requiring Hospitalization Read more
Lonza’s Fully Automated Plate-Based Robotic Solution Enables Simple, Fast and Reliable Endotoxin Detection Read more
Gilead Announces Topline Data From Phase 3 STELLAR-3 Study of Selonsertib in Bridging Fibrosis (F3) Due to NASH Read more
ACADIA Pharma Initiates Phase 3 CLARITY Program with Pimavanserin as Adjunctive Treatment for Major Depressive Disorder Read more
Hear from Amgen speaking at SMi’s 4th annual Conference and Exhibition: Pre-filled Syringes West Coast 2019 Read more
Biotheque Wallonie Bruxelles (BWB) to lead a workshop on ‘’Reinvigorate your through data quality enhancement and Financial and Economic tools’’ during the 9th Annual Biobanking Conference Read more
Forge And Basilea Enter Into Multi-Target Agreement To Discover And Develop Novel Antibiotics Read more
La Jolla Pharmaceutical Company Announces FDA’s Grant of Breakthrough Therapy Designation for LJPC-0118 for the Treatment of Severe Malaria Read more